BIOMAT Database Logo BIOMAT Database Logo

Rational modification of human synovial fluid phospholipase A2 inhibitors. 1994

M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
European Molecular Biology Laboratory, Heidelberg, Germany.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Modulation of phospholipase A2 activity in human synovial fluid by cations.
December 1987, Inflammation,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors.
June 1993, Journal of biochemistry,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Phospholipase A2 activity associated with synovial fluid cells.
January 1988, The Journal of rheumatology,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Purification and characterization of a phospholipase A2 from human osteoarthritic synovial fluid.
January 1990, Advances in experimental medicine and biology,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Multiple forms of phospholipase A2 in arthritic synovial fluid.
July 1989, Journal of biochemistry,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.
February 1985, Life sciences,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis.
January 1991, Methods in enzymology,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide.
May 1990, Biochemical pharmacology,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Monoclonal antibodies against human synovial phospholipase A2.
March 1990, Biochemical and biophysical research communications,
M T Pisabarro, and A R Ortiz, and A Palomer, and F Cabré, and L García, and R C Wade, and F Gago, and D Mauleón, and G Carganico
Biochemical characterization of soluble phospholipase A2 from rheumatoid synovial fluid.
June 1989, Agents and actions,
Copied contents to your clipboard!